These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 477592)

  • 1. [Mental disorders and prolactin secretion].
    Kordon C; Ruberg M
    Encephale; 1979; 5(2):115-20. PubMed ID: 477592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic Drug Effects on Steroid Stress Hormone Release and Possible Mechanisms Involved.
    Romanova Z; Hlavacova N; Jezova D
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuropharmacologic control of the secretion of hypophyseal hormones in man: dopamine, noradrenaline, serotonin. Clinical implications].
    Martin-du Pan R; Baumann P
    Schweiz Arch Neurol Neurochir Psychiatr; 1982; 130(1):105-43. PubMed ID: 6281876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulation of the dopaminergic mechanisms responsible for prolactin synthesis].
    Pazzi A; Accardo G
    G Clin Med; 1980 Jul; 61(7):525-9. PubMed ID: 6108891
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis.
    De Laurentiis A; Pisera D; Caruso C; Candolfi M; Mohn C; Rettori V; Seilicovich A
    Neuroimmunomodulation; 2002; 10(1):30-9. PubMed ID: 12207161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dopaminergic neurons in the hypothalamo-hypophyseal system].
    Schreiber V
    Cesk Fysiol; 1973 Mar; 22(3):213-24. PubMed ID: 4587200
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychiatric pharmacogenomics in pediatric psychopharmacology.
    Wall CA; Croarkin PE; Swintak C; Koplin BA
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):773-88. PubMed ID: 23040901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pimozide and domperidone administration on prolactin levels in neonatally estrogenized female rats.
    Aguilar E; López F; Pinilla L; Bellido C; Vaticón MD
    Rev Esp Fisiol; 1985 Jun; 41(2):183-6. PubMed ID: 4041067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurochemical strategy in the study of the mechanism of action of currently used antipsychotic drugs].
    Raevskiĭ KS
    Vestn Ross Akad Med Nauk; 1992; (7):21-5. PubMed ID: 1281703
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation between endocrinology and psychiatry. Some recent developments].
    Bursztejn C
    Nouv Presse Med; 1975 Feb; 4(7):493-4, 496-9. PubMed ID: 165466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The hypothalamo-hypophyseal dopaminergic system in rats].
    Alexandrová M
    Cesk Fysiol; 1986; 35(1):17-28. PubMed ID: 3513974
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of central catecholamines on LHRH-containing pathways.
    Fuxe K; Löfström A; Hökfelt T; Ferland L; Andersson K; Agnati L; Eneroth P; Gustafsson JA; Skett P
    Clin Obstet Gynaecol; 1978 Aug; 5(2):251-69. PubMed ID: 30560
    [No Abstract]   [Full Text] [Related]  

  • 14. Alteration of prolactin secretion by centrally acting drugs.
    Besser GM; Yeo T; Delitala G; Grossman AB
    Adv Biochem Psychopharmacol; 1980; 24():399-406. PubMed ID: 6105790
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia.
    Nair NP; Lal S; Cervantes P; Yassa R; Guyda H
    Neuropsychobiology; 1979; 5(3):136-42. PubMed ID: 431802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Some neurological and psychiatric complications of the disorders of the hypothalamo-hypophyseal system].
    Aszalós Z
    Orv Hetil; 2007 Apr; 148(16):723-30. PubMed ID: 17437948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Involvement of the dopaminergic system in the mechanisms of immunomodulation].
    Al'perina EL
    Usp Fiziol Nauk; 2014; 45(3):45-56. PubMed ID: 25715636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-3,4-dihydroxyphenylalanine (L-dopa) as an inhibitor of prolactin release.
    Jimenez AE; Voogt JL; Carr LA
    Endocrinology; 1978 Jan; 102(1):166-74. PubMed ID: 743945
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs.
    Pich EM; Collo G
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1437-47. PubMed ID: 26298833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dopaminergic neurons in the hypothalamo-hypophyseal system. II].
    Schreiber V
    Cesk Fysiol; 1974; 23(2):129-42. PubMed ID: 4846615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.